chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to an unknown number of patients of unknown age and gender. Relevant medical history and concomitant medication was not provided. On 22-OCT-2013 the patients were vaccinated with M-M-R II lot number H011907. Dose, route and frequency were not provided. On 22-OCT-2013, the patients were vaccinated with M-M-R II stored as high as 47F for up to 44 hours. No adverse effects were reported. This case was linked to MARRS case numbers 1311USA008054, 1311USA007704, 1311USA007705, 1311USA007695, 1311USA007696, 1311USA007699, 1311USA007700, 1311USA007701, 1311USA007703, 1311USA007698, 1311USA007697, 1311USA008057, 1311USA008058, 1311USA008059, 1311USA008060, 1311USA008055, 1311USA000906, 1311USA008061, 1311USA008056 (same reporter link). Additional information has been requested.
1. red, swollen, hot at the site of vaccination in my right arm 2. red, swollen, painful, lymph node under my right armpit. I am on day 3 and symptoms still exist.
Woke up with left shoulder redness about 3 in in diameter and warmth to injection site. Patient instructed to use cortisone cream
Vaccine was noted as expired by 5 days after injection. No  adverse reactions at time of injection known.
No AE reported; VAQTA was administered to a patient after experiencing a temperature excursion; This spontaneous report was received from a site manager, referring to a patient of unknown age and gender. The patient's historical drugs, medical history, concomitant therapies, drugs allergies and concurrent conditions were not reported.   On 18-JAN-2021, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated(VAQTA) lot # T022333, expiration date 11-DEC-2021 for prophylaxis (strength, route and frequency were not reported).  The temperature excursion was of 31.0 Fahrenheit degrees (°F) during 1 hour and 15 minutes. A previous temperature excursion was not reported. A digital data logger was involved. No other adverse events were reported.
Swollen, hard lip; hard lips; This case was reported by a pharmacist via call center representative and described the occurrence of lip swelling in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th August 2019, the patient received Shingrix. On 8th August 2019, 1 days after receiving Shingrix, the patient experienced lip swelling and induration. On an unknown date, the outcome of the lip swelling and induration were unknown.   It was unknown if the reporter considered the lip swelling and induration to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient's top lip was swollen and hard.
I went to a community event (held at a church) for the COVID vaccine. After the vaccine, I wanted the 15 minutes and felt ok - just hot. I went out to my car and over the next few minutes - I was getting hotter - My face was extremely hot and flushed, and hives started developing on my arms and chest. They were burning and itching; my skin was hot to the touch. My chest felt tight and my throat felt swollen, but I was able to breathe (breathe felt a little short, but I was able to take a full breathe). I was also dizzy and felt nauseous. I went to the ER, where they treated me for anaphylaxis with Benadryl, Pepcid, Breathing treatment, and a steroid. After about an hour or so I felt fine, and the dr gave me some medications to take over the next few days.
Soreness, swelling, joint pain in L shoulder. Not present prior to vaccination.  Using ibuprofen and ice to shoulder. Referal made to MD.  Con't to have symptoms 12/01/2016.
rt leg was swollen & pt was crying when legs was touched;brought pt to hosp was told by MD that pt leg was paralyzed;tx w/steroid shot;
COVID 19 Treatment; COVID 19 rebound; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old male patient received BNT162b2 (BNT162B2), on 20Feb2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 13Mar2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 20Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 48 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "HIV Positive" (unspecified if ongoing); "Hypertension" (unspecified if ongoing); "High cholesterol" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant) with onset Jun2022, outcome "unknown", described as "COVID 19 Treatment"; COVID-19 (medically significant) with onset Jun2022, outcome "unknown", described as "COVID 19 rebound". Therapeutic measures were taken as a result of vaccination failure, covid-19.  Addition information: Other medication in 2 weeks was unknown. Start date of Treatment for COVID-19 was 20Jun2022. Stop date of Treatment for COVID-19 was 25Jun2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
positive COVID-19 test; positive COVID-19 test; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced positive COVID-19 test on an unspecified date. The patient underwent lab tests and procedures which included COVID-19 test: positive on an unspecified date. The clinical outcome of positive COVID-19 test was unknown.  The batch/lot number for the vaccine, BNT162B2, was not provided and has been requested during follow up.; Sender's Comments: The reported positive COVID-19 test after COVID-19 immunization is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.
10/02/2021 at 6:00pm I started to feel very tired, chills, fever, I started to get very dizzy, and 3 days after I began to have ringing in my ears.  Now have all resolved besides the dizziness off and on mildly.
pt passed away at home; she had a positive COVID test on 1/27/22 from Lab.
At 830pm today I began to feel extremely cold. I had goosebumps and shivers but a normal body temperature 98.6F. I took a 500mg ibuprofen at 9pm and the chills went away at 950pm but I became very hot and sweaty. Temperature still normal.
Patient was setting up in the area where we were about to start Flu/COVID vaccines.  Her name was on the list to vaccine, the aide identified her and verified her name on the list, so I gave her the vaccine that was listed that she needed.  Employee came around the corner and was mortified that I had done this.  Her daughter had taken her out and got it done at pharmacy earlier in the month.   This information had been omitted to us and would've changed the situation.  The patient ambulated per self away from the area.
HIVES AND WELTS ON BACK, UNDER ARMS, IN MOUTH, ON LEGS AND IN GROIN AREA. PATIENT CAME INTO OUR FACILITY TO ASK FOR ANOTHER VACCINE INFORMATION STATEMENT ON FLU VACCINE, DESCRIBING THE SYMPTOMS THAT HAD STARTED THE EVENING OF 10/13/2010. WE SUGGESTED THAT SHE TAKE BENADRYL ORAL CAPSULES, AS DIRECTED BY THE MANUFACTURER'S DIRECTIONS ON THE PACKAGE, AND THAT SHE REPORT THIS REACTION TO HER PRIMARY CARE PHYSICIAN.
This spontaneous report as received from a nurse refers to a 14 years old female patient. No concurrent condition, medical history or allergy/drug reactions were reported. On an unspecified date, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) GARDASIL injection, lot # K005881, exp. date: 14-JAN-2017 (dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
Patient started with a red/blotchy rash in the morning. that spread to multiple red bumps That are warm to touch, itchy and burns
Patient reports not being able to raise her left arm above shoulder level without pain. She also reports that she cannot extend her arm behind her back without pain.
patient was administered all three doses x 2 due to miscommunication. no adverse effects noted during the time at the clinic.
Started feeling bad around 2:30pm the day of the shot.: Dizzy and loss of appetite. I just rested the rest of the day and was feeling better by the next morning. I went to work and started feeling bad again around 11:00am so I went home at 1:00pm with a major headache and nausea. I took some Tylenol and rested again. Today I woke up with some pain and swelling in my arm. Also some redness. Hopefully I will be back to normal by tomorrow.
This spontaneous report as received from a registered nurse refers to a patient of unknown demographics. The patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapy were not reported. On 25-JUN-2018, the patient was vaccinated with improperly stored doses of PROQUAD either from lot # R002939, expiry date: 29-JUL-2019 or lot # R006218, expiry date: 28-AUG-2019 (dose, frequency and route were not reported) for prophylaxis. Sterile diluent (DILUENT MRK INJ) was properly stored. No adverse effects were reported. No product quality complaint was involved. The PROQUAD was stored in temperature of 15 degree Fahrenheit (F) to 46 F for 14 hours on 16-JUN-2018. No previous temperature excursion was reported. A digital data logger was involved. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1808USA001261: US-009507513-1808USA004381: Original Case : 1808USA001261 US-009507513-1808USA004380: Original Case : 1808USA001261 US-009507513-1808USA004379: Original Case : 1808USA001261 US-009507513-1808USA004376: Original Case : 1808USA001261 US-009507513-1808USA004377: Original Case : 1808USA001261 US-009507513-1808USA004378: Original Case : 1808USA001261 US-009507513-1808USA004382: Original Case : 1808USA001261 US-009507513-1808USA004383: Original Case : 1808USA001261 US-009507513-1808USA004384: Original Case : 1808USA001261 US-009507513-1808USA004385: Original Case : 1808USA001261 US-009507513-1808USA004386: Original Case : 1808USA001261 US-009507513-1808USA004362: Original Case : 1808USA001261 US-009507513-1808USA004387: Original Case : 1808USA001261 US-009507513-1808USA004388: Original Case : 1808USA001261 US-009507513-1808USA004363: Original Case : 1808USA001261 US-009507513-1808USA004364: Original Case : 1808USA001261 US-009507513-1808USA004389: Original Case : 1808USA001261 US-009507513-1808USA004390: Original Case : 1808USA001261 US-009507513-1808USA004391: Original Case : 1808USA001261 US-009507513-1808USA004392: Original Case : 1808USA001261 US-009507513-1808USA004365: Original Case : 1808USA001261 US-009507513-1808USA004393: Original Case : 1808USA001261 US-009507513-1808USA004394: Original Case : 1808USA001261 US-009507513-1808USA004395: Original Case : 1808USA001261 US-009507513-1808USA004396: Original Case : 1808USA001261 US-009507513-1808USA004366: Original Case : 1808USA001261 US-009507513-1808USA004367: Original Case : 1808USA001261 US-009507513-1808USA004368: Original Case : 1808USA001261 US-009507513-1808USA004397: Original Case : 1808USA001261 US-009507513-1808USA004398: Original Case : 1808USA001261 US-009507513-1808USA004399: Original Case : 1808USA001261 US-009507513-1808USA004400: Original Case : 1808USA001261 US-009507513-1808USA004369: Original Case : 1808USA001261 US-009507513-1808USA004370: Original Case : 1808USA001261.
I still have symptoms that started 4/14/22 and are ongoing. It started off as a sore throat with 101.5 fever and chills. Then my sore throat got worse and I had congestion, runny nose and a bad headache (which I still have). Now I still have sinus pressure, cough and fatigue. The symptoms are moderate, it's getting better but at the peak it was moderate.
Heavy flow menstrual period, soaking through pad or tampon every hour; irregular menstrual bleeding; will call doctor to determine whether I need to go to er
On May 21, 2021 in the morning experienced abdominal discomfort in the navel. Then on May 22, 2021 had pain in lower right quadrant. I was advised on May 23, 2021 to go to the ER had  a CT scan of my appendix. I had a surgery done of my appendix. I was discharged on May 25,2021 and prescribed Amoxicillin-potassium clav. Then I went to a event around December 2021 we were all tested before and after the event. Then on December 29,2021 to see my father in a living facility had a rapid test was positive. I quarantined for 10 days then I retested was negative had no symptoms.
This spontaneous report as received from a physician refers to a 1 year old patient of unknown gender. No information regarding the patient's medical history and concurrent conditions was provided. On 24-APR-2017, the patient was vaccinated with an improperly stored dose of M-M-R II (rHA, recombinant human albumin), lot number M039904, (dose, dose number, injection site, route of administration and expiration date were not provided) for prophylaxis. The vaccine underwent a temperature excursion of 48 degrees Fahrenheit for 30 minutes. It was also stated that the dose of vaccine was reconstituted with properly stored sterile diluent injection. There was no Digital Data Logger involved. No adverse effects were reported. There were no previous temperature excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1704USA001661: US-009507513-1704USA001660: US-009507513-1704USA000587:
Since same day of vaccine and every day so far i have had a bad headache. Starts on left side and throughout the day it is spread to my whole head. 3-5 days after vaccine i had 1 day of nausea and then next day also nausea with a full day of vomiting.
hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced URTICARIA (hives). At the time of the report, URTICARIA (hives) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Right arm numbness and tingling, full body and muscle aches lasting 24 hours, joint pain in bilateral knees, hips and elbows lasting 24 hours.
REDNESS GREATER THAN 1 INCH AND MILD SWELLING/NONTENDER AROUND INJECTION SITE
patient reports she passed out after the 15 minute wait and she was in her car and woke up confused on her steering wheel. he mother was called. she was then seen at the clinic for adverse vaccine reaction
Mother arrived back at our office with child who was crying inconsolably for +3 hrs. Child has a local reaction to (L) thigh. Given MOTRIN in office & steroid cream.
Vaccine went into 2 to 8 degree Celsius thaw state on or about 20DEC2021 and was administered on 09FEB2022; Vaccine went into 2 to 8 degree Celsius thaw state on or about 20DEC2021 and was administered on 09FEB2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2 to 8 degree Celsius thaw state on or about 20DEC2021 and was administered on 09FEB2022) and PRODUCT STORAGE ERROR (Vaccine went into 2 to 8 degree Celsius thaw state on or about 20DEC2021 and was administered on 09FEB2022) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2022 at 7:46 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 09-Feb-2022 at 7:46 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2 to 8 degree Celsius thaw state on or about 20DEC2021 and was administered on 09FEB2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2 to 8 degree Celsius thaw state on or about 20DEC2021 and was administered on 09FEB2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2 to 8 degree Celsius thaw state on or about 20DEC2021 and was administered on 09FEB2022) and PRODUCT STORAGE ERROR (Vaccine went into 2 to 8 degree Celsius thaw state on or about 20DEC2021 and was administered on 09FEB2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Fever of 102.9 degrees developed at 4:00 AM,  treated with ibuprofen and acetaminophen. Fever accompanied by muscle aches and severe fatigue. Symptoms began to subside around 5:00 PM.
No additional AEs reported; GARDASIL 9 was administered following a temperature excursion; This spontaneous report was received from an office manager referring to a 12-year-old female patient.  The patient's concurrent conditions, medical history, and concomitant therapies were not reported.  On 22-SEP-2022, the patient was vaccinated with one dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) pre-filled syringe injection, administered as prophylaxis (there were five possible lot # of the vaccine administered: lot #1775811, expiration date: 07-DEC-2023; lot #1775827, expiration date: 27-JUN-2024; lot #W009829, expiration date: 19-OCT-2024; lot #U032681, expiration date: 26-OCT-2023; and lot #1780876, expiration date: 09-NOV-2023; however, it was not specified which one was received by the patient) (strength, dose, route of administration, anatomical location, and vaccination scheme were not provided). It was reported that the vaccines suffered from three temperature excursions with a total of 25 minutes (on 09-SEP-2022 for 8 minutes; on 16-SEP-2022 for 5 minutes; and on 03-JAN-2023 for 12 minutes). The excursions were not noted until it was noticed that an employee mistakenly cleaned the data logger more than once a day (product storage error). There were no additional adverse events (AEs) reported in the patient (no adverse event).  This is one of several reports received from the same reporter.
Daily headaches since vaccination; 4 migraines since vaccination.; This is a spontaneous report from a contactable nurse, the patient. A 38-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: EP6955) via an unspecified route of administration in the left arm on 26Mar2021 at 14:30, (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as no. The patient did not receive any other medicines within two weeks prior to the COVID-19 vaccine. The patient previously received LAMICTAL for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 30Mar2021, the patient underwent nasal swab (BinaxNOW Rapid Card) and the result was negative. On 06Apr2021, the patient underwent nasal swab and the result was pending. On 27Mar2021, the patient experienced daily headaches and 4 episodes of migraines since vaccination. Prior to vaccination, the patient had headache over a year ago and migraine over 18 months ago. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache and migraine was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
This medically confirmed spontaneous report (initial receipt: 26-Feb-2016) concerns a 49 year-old male patient. On 08-Oct-2015, the patient received AFLURIA (batch number U55406; expiry date: 30-Jun-2016 yet reported as 12-Jun-2016) 0.5mL via the intramuscular route. The AFLURIA vaccine was stored at 0.6 to 1.1 degrees Celsius (reported as 33-34 degrees Fahrenheit) multiple times. The last excursion was 0 degrees Celsius (reported as 32 degrees Fahrenheit) for no more than 24 hours. The outcome was not reported.
I have noticed increasing hearing loss and issues with language processing, along with severe headaches that were not noted prior to receiving the COVID shots.
Chest pain/like some kind of dull pain, sharp pain sometimes; Chest discomfort; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain/like some kind of dull pain, sharp pain sometimes) and CHEST DISCOMFORT (Chest discomfort) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 041J2A, 043L20A and 037620A) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concurrent medical conditions included Type 2 diabetes mellitus, Blood pressure abnormal and Blood cholesterol abnormal. Concomitant products included ATORVASTATIN for Blood cholesterol abnormal, LISINOPRIL and AMLODIPINE for Blood pressure management, METFORMIN for Type 2 diabetes mellitus.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In December 2021, the patient experienced CHEST PAIN (Chest pain/like some kind of dull pain, sharp pain sometimes) and CHEST DISCOMFORT (Chest discomfort). At the time of the report, CHEST PAIN (Chest pain/like some kind of dull pain, sharp pain sometimes) had not resolved and CHEST DISCOMFORT (Chest discomfort) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.         No treatment information was provided.   This case was linked to MOD-2021-411019 (Patient Link).
Two weeks after receiving the J,J, J vaccine I started to have tremors (uncontrollable shaking) of my lower legs while getting in or out of my car. Then about 5 weeks ago, I was sitting in our office watching You tube videos for about an hour - then my wife called out to me so I shut of the videos, stood up  and my whole body shook ( out of control ) and I fell on the floor. I went to my doctor and related my story and how I wondered if this could be a side effect from the vaccine. He said that there  was no way to prove it.